Mutual of America Capital Management LLC bought a new stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 5,010 shares of the financial services provider’s stock, valued at approximately $210,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in TRUP. Vanguard Group Inc. lifted its stake in shares of Trupanion by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock valued at $101,433,000 after purchasing an additional 32,485 shares during the period. CANADA LIFE ASSURANCE Co lifted its stake in shares of Trupanion by 2.0% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock valued at $1,188,000 after purchasing an additional 830 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Trupanion by 14.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider’s stock valued at $313,000 after buying an additional 1,441 shares during the last quarter. SG Americas Securities LLC raised its stake in Trupanion by 160.2% during the second quarter. SG Americas Securities LLC now owns 71,012 shares of the financial services provider’s stock valued at $2,088,000 after buying an additional 43,720 shares during the last quarter. Finally, Louisiana State Employees Retirement System raised its stake in Trupanion by 2.8% during the second quarter. Louisiana State Employees Retirement System now owns 18,200 shares of the financial services provider’s stock valued at $535,000 after buying an additional 500 shares during the last quarter.
Trupanion Stock Down 0.4 %
Trupanion stock opened at $53.31 on Friday. The firm has a market cap of $2.26 billion, a price-to-earnings ratio of -166.59 and a beta of 1.69. The stock has a fifty day simple moving average of $49.94 and a two-hundred day simple moving average of $40.22. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40.
Insider Buying and Selling
In related news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the sale, the director now owns 131,513 shares of the company’s stock, valued at $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Fawwad Qureshi sold 622 shares of Trupanion stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the sale, the chief financial officer now directly owns 9,867 shares of the company’s stock, valued at $519,102.87. The trade was a 5.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,538 shares of company stock valued at $988,741 over the last 90 days. Company insiders own 5.50% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on TRUP shares. Northland Securities lifted their price objective on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Bank of America lifted their price objective on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler lifted their price objective on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Finally, Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.67.
Read Our Latest Report on TRUP
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories
- Five stocks we like better than Trupanion
- What is the Shanghai Stock Exchange Composite Index?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Penny Stocks Ready to Break Out in 2025
- ETF Screener: Uses and Step-by-Step Guide
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.